MedTrace Logo

Thebaine Urine Testing

NCT07192887 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-09-25

No results posted yet for this study

Summary

To develop and validate a urine drug screen to detect thebaine.

Conditions

  • Urine Specimen Collection

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Charlotte Walter, MD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-07
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07192887 on ClinicalTrials.gov